NORLIS LIFE SCIENCES

“Empowering Health, Enriching Lives”

Our Journey started in 2021, with a commitment to provide Innovative solutions towards Healthier Society.
People with diabetes are more likely to develop heart disease or a stroke.
The prevalence of vitamin D deficiency is over 40 - 70% across India.
Kidney disease affects more than 40% of people with diabetes.
50% of men with diabetes develop erectile dysfunction
Every 20 seconds an amputation occurs in the world due to diabetes
Structure BP measurement is decisive to estimate cardiovascular risk.
Hypertension affects one-quarter of the global population and is the leading modifiable risk factor for cardiovascular disease and mortality
Isolated systolic hypertension imparts increased risk of cardiovascular mortality compared with optimal blood pressure
Previous slide
Next slide

ABOUT US

On the 5th of August 2021, the company began marketing and trading a wide range of domestic branded formulations in several major therapeutic areas, including cardiovascular, anti-diabetic, and lifestyle related therapies.

Aspiring for a leadership position in the chosen market as a Trusted Healthcare Provider, providing patients with access to high-quality, affordable medicines and innovative solutions that improve patients’ quality of life.

  • Quality Assurance
  • Affordable Healthcare Solutions
  • Patient-Centric Approach
  • Wide Therapeutic Range

Key therapies

Previous
Next

Key therapies

PROBLEM STATEMENT

NORLIS LIFE SCIENCES PRIVATE LIMITED aims to address these industry problems through innovative and sustainable solutions:

  • High Drug Costs
  • Inequitable Distribution
  • Medical Service
  • Limited Access to Healthcare
  • Counterfeit Medicines
  • Diseases related to lifestyl

PROBLEM STATEMENT

NORLIS LIFE SCIENCES PRIVATE LIMITED aims to address these industry problems through innovative and sustainable solutions:

  • High Drug Costs
  • Inequitable Distribution
  • Medical Service
  • Limited Access to Healthcare
  • Counterfeit Medicines
  • Diseases related to lifestyl

TARGET MARKET

NORLIS LIFE SCIENCES PRIVATE LIMITED will focus on serving a specific target market that aligns with our business objectives and expertise.
  • Indian Pharmaceutical Market
  • Global Pharmaceutical Market

OUR SERVICES

OUR SERVICES

  • Cardiology
  • Diabetology
  • Neurology
  • Chronic/Acute
  • Lifestyle Related Therapies

Healthy
Lives

By providing reliable and affordable
medications, we aim to contribute
to healthier lives for our patients.

Quality and Safety

Upholding the highest standards of
quality and safety, we ensure that our
medications meet regulatory
requirements and deliver consistent
results.

Empowered
Futures

Through our innovative research and development initiatives, we strive to bring cutting-edge solutions to the market that not only address existing medical needs but also pave the way for a healthier and brighter future.

Affordable Accessibility

We are committed to making essential medicines accessible and affordable to a broader segment of the population, breaking down barriers to healthcare access.

Scale Up Plan

Scale Up Plan

  • Portfolio Expansion
NORLIS will focus on expanding its product portfolio to cover a broader range of therapeutic areas beyond cardiovascular, anti-diabetic, and lifestyle-related therapies.
  • Market Diversification
We will conduct thorough market research to identify countries with high disease prevalence and demand for our products.
  • Digital Transformation
Implementing digital health solutions, such as telemedicine, remote patient monitoring, and digital marketing, will enhance patient engagement, healthcare delivery, and market outreach.
  • Brand Awareness and Marketing
A comprehensive marketing strategy will be developed to enhance brand awareness

We are trusted by more than 10,000 clients

A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with
my whole heart. I am alone, and feel the charm of existence in this spot.

Talk to us